摘要
目的:了解艾滋病患者的其他病毒学指标感染状况,有针对性地进行抗感染和抗病毒治疗,科学地评价治疗和愈后.方法:采用ELISA法,对柳州铁路局医疗机构2002～2004年的部分住院和门诊的艾滋病患者,采用病例-对照的方法进行了HIV、抗HCV、HBsAg、RPR、EBV、HSV Ⅰ、HSVⅡ、RV、CMV、TOX、CD+4等项目的检测.结果:艾滋病人的抗HCV、HBsAg、RPR、HSVⅠ、HSVⅡ、EBV的检出率显著高于对照组;88.89%(16/18)的艾滋病病人CD+4细胞低于350个/mm3;分析了艾滋病病人3种不同感染方式的实验室结果和预后.结论:艾滋病患者合并多种病原感染,刚确诊时机体的免疫功能已下降.有目的控制感染后再用抗逆转录病毒药物治疗,是提高病人生活质量,延长生存期的重要手段,也是目前防治艾滋病工作的重点.
Objective： To understand the status of AIDS patient co - infection with other virus, and for the seeking of direct anti -virus or infection therapy. Methods：In a case -control study,the HIV/AIDS patients from hospital of Liuzhou Railway Bureau were tested for HIV,anti -HCV,HBsAg,RPR,EBV,HSVⅠ ,HSVⅡ ,RV,CMV,CD4^＋ ,TOX. Results：The positive rates of anti - HCV,HBsAg,RPR,EBV, HSV Ⅰ,HSV Ⅱ in AIDS patients were significantly higher than those in controls. The percentage of CD4^＋ count lower than 350/mm^3 was 88. 89% （16/18）. Conclusion： AIDS patients merged with other infection,the immune function decreased when AIDS were diagnosed. The administration of antiretroviral drugs after the co - infection under control is the major method to prolong survival periods and to promote the quality of life.
出处
《中国卫生检验杂志》
CAS
2005年第12期1441-1443,共3页
Chinese Journal of Health Laboratory Technology
